Latest Ratings for GDRX
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Barclays | Maintains | Overweight | |
| Mar 2022 | Morgan Stanley | Maintains | Equal-Weight | |
| Mar 2022 | Raymond James | Maintains | Outperform |
Demystifying GoodRx Holdings: Insights From 5 Analyst Reviews
Where Today's News Shapes Tomorrow
